Recombinant PTK7 (Cofetuzumab Biosimilar) anticorps (PE)
Aperçu rapide pour Recombinant PTK7 (Cofetuzumab Biosimilar) anticorps (PE) (ABIN7829444)
Antigène
Type d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Classe de qualité
-
-
Fonction
- PE-conjugated Anti-PTK7(cofetuzumab biosimilar) mAb
-
Isotype
- E356D, IgG1, M358L, kappa
-
-
-
-
Indications d'application
- Flow Cyt 1 μL:test
-
Commentaires
-
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Liquid,PBS with,0.18 % BSA,0.1 %Proclin300
-
Agent conservateur
- ProClin
-
Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C
-
Stockage commentaire
- Store at 2°C-8°C for 6 months
-
Date de péremption
- 6 months
-
-
- PTK7 (Cofetuzumab Biosimilar)
-
Autre désignation
- Cofetuzumab Biosimilar
-
Classe de substances
- Biosimilar
-
Sujet
-
Synonyms Target:CCK4
Synonyms Antibody:PF-06523435,hu24 -
UniProt
- Q13308
Antigène
-